Insider Trading History of Naftzger J. Christopher

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Naftzger J. Christopher since 2011. This trader's CIK number is 1496194. At the time of last reporting, Naftzger J. Christopher was the General Counsel and CCO of Arbutus Biopharma Corp. (stock ticker symbol ABUS). Also see all insider trading activities at Arbutus Biopharma Corp.

Note that in the past Naftzger J. Christopher also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Arbutus Biopharma Corp (ABUS) by Naftzger J. Christopher

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ABUS 0 $0 11,333 $37,206 0 $0

Yearly summary of insider trading at Unilife Corp (UNIS) by Naftzger J. Christopher

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 UNIS 5,000 $22,010 0 $0 0 $0

Yearly summary of insider trading at Nabriva Therapeutics Plc (NBRV) by Naftzger J. Christopher

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 NBRV 7,000 $4,130 0 $0 0 $0


Insider trading activities at 3 companies by Naftzger J. Christopher:

1. Arbutus Biopharma Corp (ABUS)

2. Unilife Corp (UNIS)

3. Nabriva Therapeutics Plc (NBRV)

Table 1. Insider trading of Arbutus Biopharma Corp (ABUS) by Naftzger J. Christopher

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-02-04 ABUS Sale 11,333 3.28 37,206

Table 2. Insider trading of Unilife Corp (UNIS) by Naftzger J. Christopher

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-11-22 UNIS Buy 2,000 3.96 7,910
2011-03-01 UNIS Buy 3,000 4.70 14,100

Table 3. Insider trading of Nabriva Therapeutics Plc (NBRV) by Naftzger J. Christopher

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-27 NBRV Buy 7,000 .59 4,130

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Naftzger J. Christopher (General Counsel and CCO of Arbutus Biopharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.